Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.32 trillion and total revenue of $116.08 billion.
Market Cap
1.32T
Revenue
116.08B
Profits
-38.08B
PE Ratio
n/a
Profit Margin
-32.80%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 131.68B | 0.79% | 848,308 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.26B | 1.57% | 642,639 | 15.53B |
| 3 | ARGX | argenx SE | 62.63B | 0.62% | 223,390 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 58.56B | 1.89% | 10,960,486 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.96B | 0.66% | 1,286,016 | - |
| 6 | ONC | BeOne Medicines AG | 40.23B | 2.11% | 273,063 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.95B | 0.75% | 2,967,193 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.45B | 0.53% | 911,570 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.63B | 0.49% | 7,563,477 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.36B | -3.18% | 1,610,742 | 1.14B |
| 11 | BNTX | BioNTech SE | 24.83B | 2.20% | 1,233,671 | 3.03B |
| 12 | INCY | Incyte Corporation | 24.77B | 0.59% | 1,455,840 | 5.82B |
| 13 | GMAB | Genmab A/S | 19.52B | 0.57% | 1,411,692 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.40B | 0.53% | 418,001 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.96B | 0.03% | 465,442 | 4.60B |
| 16 | SMMT | Summit Therapeutics Inc. | 14.69B | 4.96% | 7,066,783 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.15B | -0.08% | 1,836,297 | 713.07M |
| 18 | EXEL | Exelixis, Inc. | 13.93B | 0.16% | 1,735,365 | 2.44B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.86B | 1.11% | 1,336,298 | 3.41B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.48B | 1.04% | 156,529 | 1.28B |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.25B | 0.69% | 898,254 | 1.66B |
| 22 | CORT | Corcept Therapeutics Incorporated | 12.09B | -0.88% | 1,275,769 | 830.81M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.39B | -2.63% | 1,319,299 | 669.50M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.34B | -1.89% | 718,760 | 776.57M |
| 25 | TECH | Bio-Techne Corporation | 11.33B | 0.21% | 2,740,155 | 1.22B |
| 26 | CYTK | Cytokinetics, Incorporated | 10.07B | -1.79% | 1,531,944 | 67.67M |
| 27 | KRYS | Krystal Biotech, Inc. | 10.06B | -2.01% | 258,560 | 440.48M |
| 28 | ABVX | ABIVAX Société Anonyme | 10.02B | -4.27% | 1,155,599 | 5.67M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.56B | -0.27% | 608,017 | 281.99M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.53B | -0.29% | 498,971 | 105.00M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.23B | -1.20% | 293,708 | 7.46M |
| 32 | IBRX | ImmunityBio, Inc. | 8.87B | 5.82% | 9,158,261 | 165.79M |
| 33 | PCVX | Vaxcyte, Inc. | 8.86B | 0.12% | 1,428,381 | - |
| 34 | IONS | Ionis Pharmaceuticals, Inc. | 8.55B | -5.11% | 6,153,012 | 874.09M |
| 35 | TWST | Twist Bioscience Corporation | 8.45B | 5.92% | 1,806,420 | 431.80M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.01B | 0.22% | 1,101,142 | - |
| 37 | IMVT | Immunovant, Inc. | 7.78B | 0.80% | 1,096,165 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.66B | 0.20% | 1,362,263 | 799.54M |
| 39 | CAI | Caris Life Sciences, Inc. | 7.36B | 7.03% | 3,642,173 | 989.61M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.05B | -2.17% | 737,367 | 239.92M |
| 41 | BLTE | Belite Bio, Inc | 6.97B | -0.45% | 213,154 | - |
| 42 | CGON | CG Oncology, Inc. | 6.54B | 1.99% | 829,543 | 6.23M |
| 43 | ORKA | Oruka Therapeutics, Inc. | 6.35B | 3.84% | 773,832 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.31B | -6.42% | 4,042,725 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | -1.50% | 488,536 | 618.07M |
| 46 | TVTX | Travere Therapeutics, Inc. | 6.20B | -0.57% | 924,538 | 591.33M |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 6.02B | 1.40% | 487,010 | 1.90M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.80B | - | 1,434,323 | - |
| 49 | ERAS | Erasca, Inc. | 5.65B | 1.76% | 2,363,157 | - |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.64B | -0.78% | 408,952 | 7.50M |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -1.34% | 158,766 | 290.54M |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.55B | 0.64% | 1,018,791 | 1.01B |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.41B | 3.50% | 7,254,655 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.12B | 2.40% | 1,520,565 | 13.39M |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.85B | 0.50% | 1,199,274 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.74B | -1.11% | 1,628,470 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.47B | -1.95% | 482,361 | 148.00K |
| 58 | MANE | Veradermics, Incorporated | 4.25B | 2.76% | 620,660 | - |
| 59 | IOVA | Iovance Biotherapeutics, Inc. | 4.19B | 7.67% | 21,037,133 | 324.97M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.18B | 1.01% | 2,400,234 | 10.35M |
| 61 | TNGX | Tango Therapeutics, Inc. | 4.14B | 3.20% | 2,010,818 | 53.81M |
| 62 | CELC | Celcuity Inc. | 4.09B | 0.10% | 1,644,782 | - |
| 63 | ELVN | Enliven Therapeutics, Inc. | 3.99B | 0.20% | 855,527 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.96B | 4.34% | 630,490 | 890.79M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.68B | -1.41% | 1,849,102 | - |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.67B | 1.17% | 524,738 | 234.13M |
| 67 | ABCL | AbCellera Biologics Inc. | 3.62B | 2.57% | 4,448,175 | 66.17M |
| 68 | LEGN | Legend Biotech Corporation | 3.59B | -0.59% | 4,907,226 | 1.27B |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.51B | 0.81% | 693,701 | 606.33M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.46B | 1.70% | 3,193,545 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.39B | 0.62% | 1,071,248 | 3.60M |
| 72 | QURE | uniQure N.V. | 3.12B | 0.94% | 709,528 | 18.67M |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.08B | 6.18% | 999,055 | 158.00K |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.06B | -2.11% | 1,720,778 | 117.00M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | 1.59% | 1,990,621 | 463.98M |
| 76 | MBX | MBX Biosciences, Inc. | 2.87B | 0.80% | 323,652 | - |
| 77 | IMNM | Immunome, Inc. | 2.79B | -0.49% | 744,599 | 4.02M |
| 78 | ZLAB | Zai Lab Limited | 2.76B | 1.82% | 1,159,814 | 449.61M |
| 79 | GPCR | Structure Therapeutics Inc. | 2.74B | -0.57% | 1,911,769 | - |
| 80 | PHVS | Pharvaris N.V. | 2.73B | 2.21% | 997,912 | - |
| 81 | NAMS | NewAmsterdam Pharma Company N.V. | 2.67B | -1.93% | 1,078,981 | 7.12M |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.67% | 1,330,847 | 36.77M |
| 83 | IRON | Disc Medicine, Inc. | 2.65B | -1.63% | 693,958 | - |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.56B | 2.66% | 1,192,931 | - |
| 85 | VRDN | Viridian Therapeutics, Inc. | 2.52B | 4.52% | 1,300,759 | 71.13M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.45B | -2.85% | 1,708,230 | - |
| 87 | PGEN | Precigen, Inc. | 2.45B | - | 2,825,652 | 85.72M |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | 0.05% | 1,044,174 | 959.90M |
| 89 | BEAM | Beam Therapeutics Inc. | 2.41B | 0.54% | 1,458,587 | 156.04M |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.37B | 1.52% | 10,542,378 | - |
| 91 | OCUL | Ocular Therapeutix, Inc. | 2.35B | 2.19% | 1,622,980 | 52.06M |
| 92 | NKTR | Nektar Therapeutics | 2.34B | -1.81% | 1,221,747 | 54.59M |
| 93 | TRVI | Trevi Therapeutics, Inc. | 2.26B | -0.06% | 1,062,473 | - |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | 2.30% | 2,192,972 | 1.97B |
| 95 | PVLA | Palvella Therapeutics, Inc. | 2.19B | 1.04% | 223,046 | - |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | 1.93% | 753,422 | 311.51M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.11B | 0.87% | 196,924 | 20.00M |
| 98 | NUVB | Nuvation Bio Inc. | 2.09B | -2.14% | 10,029,905 | 169.90M |
| 99 | URGN | UroGen Pharma Ltd. | 2.08B | 0.78% | 537,924 | 188.73M |
| 100 | ZBIO | Zenas BioPharma, Inc. | 2.08B | 2.54% | 634,637 | 1.00M |
| 101 | KOD | Kodiak Sciences Inc. | 2.08B | 0.76% | 547,787 | - |
| 102 | GENB | Generate Biomedicines, Inc. | 2.05B | 1.78% | 1,533,398 | 26.48M |
| 103 | ADMA | ADMA Biologics, Inc. | 2.05B | -0.98% | 3,067,122 | 512.28M |
| 104 | VCEL | Vericel Corporation | 2.03B | 3.29% | 615,243 | 306.30M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -1.13% | 762,208 | 98.34M |
| 106 | MESO | Mesoblast Limited | 1.96B | -2.97% | 173,208 | 120.25M |
| 107 | GHRS | GH Research PLC | 1.91B | 2.54% | 126,430 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.91B | 1.96% | 439,858 | 27.59M |
| 109 | BHVN | Biohaven Ltd. | 1.91B | -0.55% | 1,648,658 | - |
| 110 | ZYME | Zymeworks Inc. | 1.91B | 2.32% | 563,582 | 37.13M |
| 111 | COAG | Hemab Therapeutics Holdings, Inc. | 1.89B | 2.72% | 459,392 | - |
| 112 | SEPN | Septerna, Inc. | 1.85B | 2.70% | 356,010 | 98.88M |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.83B | 6.56% | 17,102,516 | 54.86M |
| 114 | NBTX | Nanobiotix S.A. | 1.82B | -3.46% | 128,502 | 38.27M |
| 115 | XNCR | Xencor, Inc. | 1.82B | 0.49% | 858,320 | 104.97M |
| 116 | VIR | Vir Biotechnology, Inc. | 1.82B | 1.37% | 1,841,510 | 303.23M |
| 117 | KARD | Kardigan, Inc. | 1.78B | 3.02% | 806,572 | - |
| 118 | KLRA | Kailera Therapeutics, Inc. | 1.78B | -1.36% | 872,425 | - |
| 119 | DMRA | Damora Therapeutics, Inc. | 1.75B | 1.03% | 370,950 | - |
| 120 | LKFT | Lakefront Biotherapeutics NV | 1.75B | -0.37% | 249,309 | 1.13B |
| 121 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.74B | 2.37% | 2,639,451 | 208.78M |
| 122 | BRVE | Braveheart Bio, Inc. | 1.73B | 1.76% | 209,181 | - |
| 123 | IMCR | Immunocore Holdings plc | 1.67B | -0.26% | 318,385 | 430.78M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 1.11% | 2,598,559 | 59.51M |
| 125 | FTRE | Fortrea Holdings Inc. | 1.66B | 1.22% | 2,430,280 | 2.68B |
| 126 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 0.94% | 1,142,335 | 252.25M |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | -0.20% | 7,909,133 | 5.49M |
| 128 | INBX | Inhibrx Biosciences, Inc. | 1.63B | 1.10% | 239,991 | 1.30M |
| 129 | ANAB | AnaptysBio, Inc. | 1.60B | 0.45% | 436,841 | 232.39M |
| 130 | NVAX | Novavax, Inc. | 1.58B | 1.80% | 3,366,870 | 413.80M |
| 131 | AVLN | Avalyn Pharma Inc. | 1.55B | 4.20% | 494,137 | - |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.54B | 1.71% | 426,337 | - |
| 133 | INVA | Innoviva, Inc. | 1.51B | 1.16% | 1,110,110 | 440.00M |
| 134 | AAPG | Ascentage Pharma Group International | 1.50B | 1.93% | 3,821 | 94.61M |
| 135 | LTGO | Latigo Biotherapeutics, Inc. | 1.50B | 2.21% | 164,838 | - |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.50B | 13.80% | 2,066,090 | - |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.45B | 0.47% | 242,770 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -1.48% | 538,336 | - |
| 139 | ABSI | Absci Corporation | 1.39B | -1.46% | 3,004,632 | 1.56M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.37B | 0.28% | 589,271 | 20.00M |
| 141 | VOR | Vor Biopharma Inc. | 1.37B | 3.50% | 888,647 | - |
| 142 | SVRA | Savara Inc. | 1.36B | 0.75% | 1,310,099 | - |
| 143 | TRAX | First Tracks Biotherapeutics, Inc. | 1.34B | 3.10% | 488,122 | - |
| 144 | RARE | Ultragenyx Pharmaceutical Inc. | 1.34B | -4.83% | 5,929,198 | 717.00M |
| 145 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.21% | 386,684 | - |
| 146 | SPTX | Seaport Therapeutics, Inc. | 1.32B | 6.56% | 174,186 | - |
| 147 | CGEM | Cullinan Therapeutics, Inc. | 1.31B | -0.92% | 1,415,351 | - |
| 148 | ORIC | ORIC Pharmaceuticals, Inc. | 1.31B | 5.07% | 1,618,195 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.29B | -0.56% | 330,074 | 10.06M |
| 150 | OMER | Omeros Corporation | 1.26B | -4.49% | 1,688,093 | 38.42M |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.24B | -1.00% | 453,306 | - |
| 152 | MGTX | MeiraGTx Holdings plc | 1.24B | 0.70% | 492,244 | 397.50M |
| 153 | REPL | Replimune Group, Inc. | 1.24B | 1.47% | 2,350,704 | - |
| 154 | MNKD | MannKind Corporation | 1.21B | - | 3,129,356 | 393.63M |
| 155 | ALMS | Alumis Inc. | 1.19B | 0.44% | 4,028,056 | 7.40M |
| 156 | GLUE | Monte Rosa Therapeutics, Inc. | 1.19B | -1.21% | 1,746,518 | 28.73M |
| 157 | SLBT | SL Science Holding Limited | 1.18B | 0.49% | 315,266 | 3.27M |
| 158 | IMTX | Immatics N.V. | 1.18B | -1.93% | 378,590 | 47.65M |
| 159 | ODTX | Odyssey Therapeutics, Inc. | 1.16B | -1.50% | 218,958 | 99.00K |
| 160 | JBIO | Jade Biosciences, Inc. | 1.16B | 1.62% | 829,513 | - |
| 161 | ATTO | Attovia Therapeutics, Inc. | 1.12B | 7.59% | 286,054 | 1.80M |
| 162 | OBX | Obsidian Therapeutics, Inc. | 1.12B | 1.69% | 455,456 | - |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 1.55% | 1,091,520 | - |
| 164 | MLTX | MoonLake Immunotherapeutics | 1.08B | 1.36% | 2,332,069 | - |
| 165 | APMD | Apnimed, Inc. | 1.06B | -2.59% | 263,415 | 115.12M |
| 166 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.23% | 869,760 | 24.00M |
| 167 | KURA | Kura Oncology, Inc. | 1.03B | 1.49% | 1,457,585 | 77.23M |
| 168 | ANL | Adlai Nortye Group Ltd. | 1.03B | 4.73% | 175,550 | 18.06M |
| 169 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 3,803,256 | 181.72M |
| 170 | FTH | Faeth Therapeutics, Inc. | 1.01B | 4.41% | 265,785 | - |
| 171 | HELP | Cybin Inc. | 994.35M | 4.93% | 1,615,497 | - |
| 172 | SGP | SpyGlass Pharma, Inc. | 958.62M | 4.14% | 130,173 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 957.95M | 2.24% | 2,380,831 | - |
| 174 | SLDB | Solid Biosciences Inc. | 937.15M | 0.46% | 1,025,184 | - |
| 175 | IVA | Inventiva S.A. | 928.49M | -3.48% | 1,493,402 | 7.94M |
| 176 | WVE | Wave Life Sciences, Inc. | 902.48M | -0.22% | 2,869,840 | 65.37M |
| 177 | OLMA | Olema Pharmaceuticals, Inc. | 900.35M | 0.68% | 1,822,822 | - |
| 178 | TBPH | Theravance Biopharma, Inc. | 884.18M | 0.12% | 243,260 | 104.31M |
| 179 | LXRX | Lexicon Pharmaceuticals, Inc. | 881.01M | -1.00% | 1,773,779 | 41.47M |
| 180 | GERN | Geron Corporation | 880.19M | 1.48% | 16,979,115 | 204.56M |
| 181 | ARDX | Ardelyx, Inc. | 877.14M | -1.68% | 4,364,454 | 450.89M |
| 182 | IMMX | Immix Biopharma, Inc. | 873.50M | 0.58% | 1,079,527 | - |
| 183 | AVTX | Avalo Therapeutics, Inc. | 867.73M | 0.37% | 908,327 | 59.00K |
| 184 | RIGL | Rigel Pharmaceuticals, Inc. | 847.13M | -4.00% | 335,724 | 276.79M |
| 185 | DSGN | Design Therapeutics, Inc. | 846.10M | -7.59% | 1,255,451 | - |
| 186 | CBIO | Crescent Biopharma, Inc. | 842.32M | 1.39% | 251,175 | 11.88M |
| 187 | CLYM | Climb Bio, Inc. | 836.27M | 2.18% | 1,094,427 | - |
| 188 | ACRS | Aclaris Therapeutics, Inc. | 830.20M | 6.02% | 5,838,379 | 8.22M |
| 189 | CADL | Candel Therapeutics, Inc. | 816.84M | 1.18% | 940,801 | - |
| 190 | SLN | Silence Therapeutics plc | 786.33M | 0.31% | 1,045,190 | 615.00K |
| 191 | PHAR | Pharming Group N.V. | 764.06M | -3.48% | 19,681 | 366.48M |
| 192 | NVCT | Nuvectis Pharma, Inc. | 760.78M | -2.67% | 203,423 | - |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 760.16M | 4.48% | 970,156 | 92.01M |
| 194 | ANNX | Annexon, Inc. | 748.84M | 0.25% | 2,896,023 | - |
| 195 | ACHV | Achieve Life Sciences, Inc. | 743.99M | 2.41% | 1,430,325 | - |
| 196 | DBVT | DBV Technologies S.A. | 733.56M | 4.22% | 269,583 | 5.04M |
| 197 | MPLT | MapLight Therapeutics, Inc. | 730.82M | 1.15% | 327,550 | - |
| 198 | MNPR | Monopar Therapeutics Inc. | 727.06M | -1.76% | 106,566 | - |
| 199 | AURA | Aura Biosciences, Inc. | 726.97M | 0.14% | 467,410 | - |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 715.57M | 0.33% | 629,155 | 136.07M |
| 201 | GYRE | Gyre Therapeutics, Inc. | 709.37M | -0.59% | 104,117 | 109.82M |
| 202 | NGNE | Neurogene Inc. | 704.60M | -0.76% | 194,665 | 925.00K |
| 203 | CTMX | CytomX Therapeutics, Inc. | 697.28M | -2.74% | 6,131,823 | 18.30M |
| 204 | PHAT | Phathom Pharmaceuticals, Inc. | 689.45M | 3.83% | 1,316,346 | 239.66M |
| 205 | VSTM | Verastem, Inc. | 680.13M | 2.60% | 1,514,527 | 87.53M |
| 206 | MDXG | MiMedx Group, Inc. | 676.33M | 1.53% | 888,918 | 355.17M |
| 207 | SGMT | Sagimet Biosciences Inc. | 676.29M | - | 516,686 | - |
| 208 | BLSM | BlossomHill Therapeutics, Inc. | 666.19M | 4.22% | 254,306 | - |
| 209 | OCS | Oculis Holding AG | 654.36M | 0.38% | 153,182 | 1.45M |
| 210 | OABI | OmniAb, Inc. | 651.35M | 10.07% | 1,599,008 | 38.46M |
| 211 | ALT | Altimmune, Inc. | 641.91M | 0.92% | 2,465,544 | 31.00K |
| 212 | DRUG | Bright Minds Biosciences Inc. | 631.27M | 0.32% | 42,053 | - |
| 213 | VALN | Valneva SE | 629.46M | 0.15% | 13,400 | 163.30M |
| 214 | STTK | Shattuck Labs, Inc. | 622.25M | - | 821,853 | 1.00M |
| 215 | CRMD | CorMedix Inc. | 614.98M | 0.77% | 919,604 | 462.25M |
| 216 | ALLO | Allogene Therapeutics, Inc. | 614.97M | - | 7,750,773 | 4.64M |
| 217 | AGMB | AgomAb Therapeutics NV | 604.77M | -5.97% | 86,185 | - |
| 218 | ASMB | Assembly Biosciences, Inc. | 589.64M | -2.82% | 290,472 | 74.85M |
| 219 | TECX | Tectonic Therapeutic, Inc. | 580.81M | 2.27% | 145,001 | - |
| 220 | RGNX | REGENXBIO Inc. | 573.65M | 1.88% | 858,446 | 174.48M |
| 221 | PRME | Prime Medicine, Inc. | 565.74M | 1.60% | 1,616,906 | 4.07M |
| 222 | CTNM | Contineum Therapeutics, Inc. | 557.55M | - | 608,027 | - |
| 223 | SCTX | Scribe Therapeutics Inc. | 556.97M | -1.08% | 138,336 | 33.30M |
| 224 | ARVN | Arvinas, Inc. | 549.24M | -0.59% | 1,471,568 | 316.70M |
| 225 | PROK | ProKidney Corp. | 547.20M | 0.56% | 952,586 | 818.00K |
| 226 | OVID | Ovid Therapeutics Inc. | 535.12M | 1.86% | 1,199,226 | 1.58M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 530.90M | -4.16% | 431,556 | - |
| 228 | AUTL | Autolus Therapeutics plc | 516.36M | 3.19% | 1,480,607 | 117.39M |
| 229 | CAPR | Capricor Therapeutics, Inc. | 512.20M | 5.26% | 2,907,523 | 11.13M |
| 230 | EIKN | Eikon Therapeutics, Inc. | 506.98M | 4.70% | 708,959 | - |
| 231 | ZURA | Zura Bio Limited | 499.27M | - | 1,045,388 | - |
| 232 | IRD | Opus Genetics, Inc. | 496.68M | -1.16% | 2,551,623 | 9.86M |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 495.75M | -0.78% | 242,706 | 251.00K |
| 234 | CABA | Cabaletta Bio, Inc. | 493.38M | 6.59% | 6,312,237 | - |
| 235 | ENTX | Entera Bio Ltd. | 488.26M | -0.70% | 99,001 | 42.00K |
| 236 | RLMD | Relmada Therapeutics, Inc. | 473.61M | -1.77% | 1,264,729 | - |
| 237 | PRLD | Prelude Therapeutics Incorporated | 472.75M | - | 275,344 | 22.42M |
| 238 | DNA | Ginkgo Bioworks Holdings, Inc. | 472.06M | 3.85% | 1,030,256 | 132.42M |
| 239 | PBYI | Puma Biotechnology, Inc. | 471.81M | 0.22% | 256,650 | 231.24M |
| 240 | KYTX | Kyverna Therapeutics, Inc. | 457.64M | 1.93% | 533,908 | - |
| 241 | PRTA | Prothena Corporation plc | 454.85M | -0.78% | 374,871 | 54.53M |
| 242 | VOGX | Vogenx, Inc. | 451.21M | -0.89% | 106,197 | - |
| 243 | SPRY | ARS Pharmaceuticals, Inc. | 447.51M | -5.46% | 2,166,698 | 116.93M |
| 244 | RZLT | Rezolute, Inc. | 443.98M | 0.71% | 828,016 | - |
| 245 | IKT | Inhibikase Therapeutics, Inc. | 435.16M | 2.14% | 482,935 | 1.00 |
| 246 | ARCT | Arcturus Therapeutics Holdings Inc. | 434.59M | 3.80% | 596,188 | 29.37M |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 426.69M | 0.19% | 272,760 | - |
| 248 | CCCC | C4 Therapeutics, Inc. | 421.98M | -2.28% | 1,485,661 | 35.04M |
| 249 | EDIT | Editas Medicine, Inc. | 420.81M | 1.48% | 1,690,985 | 47.01M |
| 250 | INDP | Indaptus Therapeutics, Inc. | 418.38M | 13.36% | 1,386,263 | - |
| 251 | BNTC | Benitec Biopharma Inc. | 415.00M | -0.90% | 106,355 | - |
| 252 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 404.88M | 2.02% | 956,104 | - |
| 253 | TTRX | Turn Therapeutics Inc. | 400.65M | 5.99% | 131,339 | - |
| 254 | LRMR | Larimar Therapeutics, Inc. | 394.57M | -3.57% | 1,169,126 | - |
| 255 | VTVT | vTv Therapeutics Inc. | 390.64M | -1.66% | 22,054 | 36.84M |
| 256 | GALT | Galectin Therapeutics Inc. | 387.26M | -1.79% | 338,529 | - |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 382.13M | 1.23% | 280,228 | 65.26M |
| 258 | EVMN | Evommune, Inc. | 378.53M | -1.04% | 350,198 | 10.00M |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 376.53M | 2.39% | 1,293,346 | - |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 375.92M | -2.19% | 186,008 | 59.22M |
| 261 | SION | Sionna Therapeutics, Inc. | 373.45M | 5.22% | 1,218,419 | - |
| 262 | EYPT | EyePoint, Inc. | 366.40M | 0.47% | 2,528,692 | 2.79M |
| 263 | IPSC | Century Therapeutics, Inc. | 362.15M | 3.09% | 507,594 | 109.16M |
| 264 | OCGN | Ocugen, Inc. | 359.46M | 3.92% | 6,680,320 | 4.58M |
| 265 | XFOR | X4 Pharmaceuticals, Inc. | 358.91M | 3.43% | 1,017,937 | 15.85M |
| 266 | PALI | Palisade Bio, Inc. | 357.25M | -0.49% | 1,813,401 | 500.00K |
| 267 | OBIO | Orchestra BioMed Holdings, Inc. | 354.62M | -3.59% | 383,616 | 31.98M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 353.21M | 1.24% | 145,326 | - |
| 269 | CMPX | Compass Therapeutics, Inc. | 352.97M | -2.00% | 2,270,097 | 850.00K |
| 270 | LXEO | Lexeo Therapeutics, Inc. | 345.40M | -0.94% | 1,263,639 | - |
| 271 | ZNTL | Zentalis Pharmaceuticals, Inc. | 331.35M | -0.28% | 750,204 | 26.87M |
| 272 | QTTB | Q32 Bio Inc. | 324.78M | -1.71% | 870,605 | 53.74M |
| 273 | AGEN | Agenus Inc. | 321.00M | 2.74% | 752,198 | 132.69M |
| 274 | UPB | Upstream Bio, Inc. | 318.22M | 1.40% | 491,023 | 3.16M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 314.81M | 1.47% | 237,474 | 114.70K |
| 276 | IFRX | InflaRx N.V. | 312.42M | 1.44% | 545,777 | -11.54K |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 311.38M | 1.18% | 817,761 | 215.72M |
| 278 | ABEO | Abeona Therapeutics Inc. | 310.51M | 0.18% | 1,406,111 | 25.52M |
| 279 | VCRE | Vicore Pharma Holding AB (publ) | 305.57M | 3.53% | 74,883 | 412.09K |
| 280 | CUVL | Clinuvel Pharmaceuticals Limited | 298.96M | -0.84% | 13,881 | 65.05M |
| 281 | FULC | Fulcrum Therapeutics, Inc. | 289.17M | -0.26% | 706,433 | 80.00M |
| 282 | PYXS | Pyxis Oncology, Inc. | 286.09M | 6.85% | 699,690 | 11.04M |
| 283 | STRO | Sutro Biopharma, Inc. | 280.39M | 0.30% | 251,659 | 45.70M |
| 284 | IMRX | Immuneering Corporation | 280.14M | 1.41% | 493,691 | - |
| 285 | FATE | Fate Therapeutics, Inc. | 279.78M | 1.08% | 645,188 | 6.49M |
| 286 | LYEL | Lyell Immunopharma, Inc. | 277.64M | -5.27% | 104,413 | 27.00K |
| 287 | BCYC | Bicycle Therapeutics plc | 272.27M | 0.78% | 209,372 | 61.21M |
| 288 | LCTX | Lineage Cell Therapeutics, Inc. | 270.61M | 5.94% | 1,839,982 | 13.08M |
| 289 | YDES | YD Bio Limited | 269.32M | -4.25% | 523,341 | 510.36K |
| 290 | MGNX | MacroGenics, Inc. | 267.54M | 5.00% | 431,465 | 175.14M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 266.70M | - | 167,036 | 4.22M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 266.18M | -0.77% | 879,719 | - |
| 293 | ACIU | AC Immune SA | 264.48M | -3.62% | 111,829 | 21.67M |
| 294 | IVVD | Invivyd, Inc. | 262.87M | 13.53% | 3,801,561 | 58.37M |
| 295 | PRQR | ProQR Therapeutics N.V. | 262.49M | - | 630,051 | 21.05M |
| 296 | FHTX | Foghorn Therapeutics Inc. | 258.92M | -1.36% | 399,647 | 36.74M |
| 297 | TRDA | Entrada Therapeutics, Inc. | 254.20M | 3.68% | 336,093 | 4.69M |
| 298 | ALEC | Alector, Inc. | 246.76M | 3.27% | 2,467,753 | 13.86M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 243.25M | -1.83% | 110,245 | 1.48M |
| 300 | AVXL | Anavex Life Sciences Corp. | 241.01M | -0.76% | 658,131 | - |
| 301 | NGEN | NervGen Pharma Corp. | 236.01M | 0.46% | 237,982 | - |
| 302 | GLSI | Greenwich LifeSciences, Inc. | 235.59M | 3.88% | 100,212 | - |
| 303 | CGEN | Compugen Ltd. | 234.92M | 0.40% | 144,470 | 74.00M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 232.03M | -0.97% | 166,026 | 7.15M |
| 305 | TARA | Protara Therapeutics, Inc. | 231.06M | 2.36% | 735,184 | - |
| 306 | VRXA | Veraxa Biotech AG | 230.49M | -1.21% | 64,665 | 29.54K |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 225.32M | -0.36% | 520,111 | - |
| 308 | PLX | Protalix BioTherapeutics, Inc. | 223.18M | 4.92% | 952,140 | 80.62M |
| 309 | KROS | Keros Therapeutics, Inc. | 222.26M | 1.17% | 342,163 | 15.01M |
| 310 | CUE | Cue Biopharma, Inc. | 221.93M | 6.30% | 136,559 | 37.66M |
| 311 | YARW | Yarrow Bioscience, Inc. | 221.61M | -2.78% | 82,946 | - |
| 312 | CHRS | Coherus Oncology, Inc. | 220.94M | 7.52% | 1,274,819 | 50.94M |
| 313 | ADAG | Adagene Inc. | 219.56M | -3.82% | 154,864 | 9.29M |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 213.40M | -1.15% | 27,890 | 1.80M |
| 315 | SRZN | Surrozen, Inc. | 209.68M | -6.11% | 198,202 | 11.51M |
| 316 | NKTX | Nkarta, Inc. | 209.14M | 0.34% | 491,725 | - |
| 317 | ARMP | Armata Pharmaceuticals, Inc. | 206.36M | 3.16% | 4,743,505 | 5.54M |
| 318 | ANTX | AN2 Therapeutics, Inc. | 206.04M | 0.92% | 221,485 | - |
| 319 | MSLE | Satellos Bioscience Inc. | 205.97M | 0.41% | 7,735 | - |
| 320 | PEPG | PepGen Inc. | 205.70M | -0.34% | 718,423 | - |
| 321 | KRRO | Korro Bio, Inc. | 204.39M | 0.51% | 264,802 | 2.38M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 201.77M | -4.45% | 394,094 | - |
| 323 | TNXP | Tonix Pharmaceuticals Holding Corp. | 201.18M | -1.18% | 454,680 | 29.10M |
| 324 | VYGR | Voyager Therapeutics, Inc. | 196.56M | - | 314,806 | 34.46M |
| 325 | ORMP | Oramed Pharmaceuticals Inc. | 194.26M | 0.21% | 134,994 | 2.00M |
| 326 | NERV | Minerva Neurosciences, Inc. | 191.47M | -3.37% | 119,399 | - |
| 327 | ACOG | Alpha Cognition Inc. | 189.69M | -2.13% | 145,753 | 15.26M |
| 328 | DTIL | Precision BioSciences, Inc. | 189.35M | -4.32% | 233,750 | 45.06M |
| 329 | NMRA | Neumora Therapeutics, Inc. | 187.78M | -3.90% | 555,257 | - |
| 330 | NBP | NovaBridge Biosciences | 186.76M | 1.26% | 206,582 | - |
| 331 | MDWD | MediWound Ltd. | 179.19M | 5.87% | 167,850 | 11.86M |
| 332 | RNA | Atrium Therapeutics, Inc. | 174.65M | -1.45% | 255,713 | 35.84M |
| 333 | IPHA | Innate Pharma S.A. | 169.96M | -1.07% | 20,555 | 10.57M |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 167.33M | -0.47% | 481,418 | 1.50M |
| 335 | SPRB | Spruce Biosciences, Inc. | 163.39M | 5.87% | 102,542 | 697.00K |
| 336 | CDXS | Codexis, Inc. | 162.07M | 1.02% | 477,568 | 77.68M |
| 337 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 156.28M | -0.49% | 8,376,548 | - |
| 338 | HUMA | Humacyte, Inc. | 155.84M | -1.16% | 3,164,573 | 2.12M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 155.37M | 8.27% | 3,081,623 | 1.34M |
| 340 | OTLK | Outlook Therapeutics, Inc. | 155.30M | -3.35% | 2,848,345 | -1.16M |
| 341 | MENS | Jyong Biotech Ltd. | 154.41M | 4.52% | 37,920 | - |
| 342 | IMUX | Immunic, Inc. | 153.23M | -1.66% | 252,979 | - |
| 343 | MOLN | Molecular Partners AG | 153.18M | -3.83% | 1,630 | 856.30K |
| 344 | KZIA | Kazia Therapeutics Limited | 152.93M | -0.27% | 153,210 | 1.27M |
| 345 | NRXP | NRx Pharmaceuticals, Inc. | 150.99M | 2.65% | 1,205,395 | 3.39M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 143.45M | -2.65% | 670,947 | - |
| 347 | LENZ | LENZ Therapeutics, Inc. | 140.45M | -1.11% | 743,927 | 21.48M |
| 348 | CRBU | Caribou Biosciences, Inc. | 138.30M | 1.57% | 1,679,370 | 10.04M |
| 349 | CNXU | Conexeu Sciences Inc. | 133.79M | 12.11% | 191,468 | - |
| 350 | MIST | Milestone Pharmaceuticals Inc. | 133.78M | -3.13% | 2,583,438 | 2.34M |
| 351 | EQ | Equillium, Inc. | 132.84M | -0.71% | 261,875 | 4.39M |
| 352 | HURA | TuHURA Biosciences, Inc. | 130.64M | - | 167,171 | - |
| 353 | BMEA | Biomea Fusion, Inc. | 129.02M | 2.30% | 1,552,477 | - |
| 354 | CLLS | Cellectis S.A. | 126.27M | -40.97% | 1,176,494 | 63.82M |
| 355 | ENGN | enGene Therapeutics Inc. | 125.94M | 4.44% | 460,476 | - |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 122.01M | -5.60% | 3,276,004 | 65.34K |
| 357 | OKUR | OnKure Therapeutics, Inc. | 121.49M | -3.23% | 105,157 | - |
| 358 | AARD | Aardvark Therapeutics, Inc. | 121.46M | 8.19% | 216,855 | - |
| 359 | PMN | ProMIS Neurosciences, Inc. | 118.91M | -2.21% | 21,787 | - |
| 360 | BDTX | Black Diamond Therapeutics, Inc. | 116.63M | 2.53% | 514,131 | 70.00M |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 116.51M | -0.81% | 372,699 | 4.88M |
| 362 | NAUT | Nautilus Biotechnology, Inc. | 115.33M | -11.15% | 1,234,968 | 190.00K |
| 363 | TLSA | Tiziana Life Sciences Ltd | 115.11M | -7.27% | 565,007 | - |
| 364 | CBUS | Cibus, Inc. | 113.88M | -5.10% | 132,949 | 4.35M |
| 365 | GNLX | Genelux Corporation | 113.82M | 2.01% | 297,536 | 8.00K |
| 366 | VANI | Vivani Medical, Inc. | 113.66M | -0.79% | 151,670 | - |
| 367 | PMVP | PMV Pharmaceuticals, Inc. | 110.25M | 4.29% | 1,109,775 | - |
| 368 | COYA | Coya Therapeutics, Inc. | 108.84M | 5.94% | 201,467 | 8.02M |
| 369 | CNTB | Connect Biopharma Holdings Limited | 108.63M | -15.44% | 2,663,972 | 2.95M |
| 370 | PYPD | PolyPid Ltd. | 108.26M | 3.50% | 180,687 | - |
| 371 | TENX | Tenax Therapeutics, Inc. | 106.54M | - | 2,007,147 | - |
| 372 | SEER | Seer, Inc. | 105.76M | -2.05% | 161,264 | 14.22M |
| 373 | ACET | Adicet Bio, Inc. | 104.84M | 2.31% | 124,754 | - |
| 374 | ONCY | Oncolytics Biotech Inc. | 103.63M | 9.01% | 1,400,449 | - |
| 375 | CRDF | Cardiff Oncology, Inc. | 101.91M | 8.26% | 2,099,018 | 508.00K |
| 376 | PLYX | Polaryx Therapeutics, Inc. | 100.69M | 0.50% | 23,059 | - |
| 377 | GUTS | Fractyl Health, Inc. | 97.35M | -4.44% | 1,964,716 | 3.00K |
| 378 | CGTX | Cognition Therapeutics, Inc. | 96.04M | 2.77% | 231,078 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 95.26M | 1.45% | 376,376 | - |
| 380 | NTHI | NeOnc Technologies Holdings, Inc. | 93.96M | 2.72% | 290,505 | 39.99K |
| 381 | ATRA | Atara Biotherapeutics, Inc. | 92.85M | -1.39% | 50,844 | 6.19M |
| 382 | MNOV | MediciNova, Inc. | 92.04M | 3.31% | 68,447 | 920.48K |
| 383 | ICCC | ImmuCell Corporation | 88.19M | -1.42% | 14,813 | 30.68M |
| 384 | ALDX | Aldeyra Therapeutics, Inc. | 88.08M | 8.96% | 1,168,289 | - |
| 385 | RLYB | Rallybio Corporation | 87.68M | -2.19% | 14,255 | 646.00K |
| 386 | MAIA | MAIA Biotechnology, Inc. | 84.55M | 6.92% | 800,151 | - |
| 387 | FBIO | Fortress Biotech, Inc. | 84.38M | 0.40% | 226,374 | 68.47M |
| 388 | NTRB | Nutriband Inc. | 84.18M | -0.50% | 108,625 | 1.62M |
| 389 | PTHS | Pelthos Therapeutics Inc. | 84.00M | 0.18% | 54,623 | 43.30M |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 83.99M | -2.00% | 208,218 | - |
| 391 | VRCA | Verrica Pharmaceuticals Inc. | 82.11M | -2.65% | 43,101 | 30.32M |
| 392 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | - | 49,821 | - |
| 393 | KLRS | Kalaris Therapeutics, Inc. | 78.56M | -2.37% | 57,632 | - |
| 394 | OSTX | OS Therapies Incorporated | 78.41M | 1.19% | 987,801 | - |
| 395 | IBIO | iBio, Inc. | 77.17M | -0.41% | 325,234 | 100.00K |
| 396 | RNXT | RenovoRx, Inc. | 76.27M | -3.98% | 579,669 | 1.98M |
| 397 | GANX | Gain Therapeutics, Inc. | 75.94M | -0.57% | 360,116 | - |
| 398 | CING | Cingulate Inc. | 75.18M | 2.99% | 101,216 | - |
| 399 | BSEM | BioStem Technologies, Inc. | 75.15M | -2.32% | 140,506 | 34.59M |
| 400 | OKYO | OKYO Pharma Limited | 73.47M | - | 133,797 | - |
| 401 | NRXS | NeurAxis, Inc. | 72.21M | 0.17% | 179,896 | 5.32M |
| 402 | PLRX | Pliant Therapeutics, Inc. | 71.21M | -1.71% | 208,876 | - |
| 403 | ATHE | Alterity Therapeutics Limited | 70.85M | -4.69% | 32,998 | 2.50M |
| 404 | LONA | LeonaBio, Inc. | 70.38M | 7.95% | 23,324 | - |
| 405 | CSBR | Champions Oncology, Inc. | 68.36M | -3.53% | 1,792 | 60.66M |
| 406 | RNTX | Rein Therapeutics Inc. | 68.24M | 0.76% | 346,766 | - |
| 407 | ALPS | Alps Group Inc | 66.56M | - | 61,129 | 3.74M |
| 408 | SPRO | Spero Therapeutics, Inc. | 66.39M | 0.88% | 267,141 | 47.00M |
| 409 | XBIT | XBiotech Inc. | 66.16M | -0.91% | 21,880 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 65.79M | 3.49% | 16,524 | - |
| 411 | GOSS | Gossamer Bio, Inc. | 65.38M | -0.28% | 325,484 | 53.29M |
| 412 | INMB | INmune Bio Inc. | 64.67M | 4.95% | 370,059 | 50.00K |
| 413 | BOLD | Boundless Bio, Inc. | 64.60M | 0.35% | 29,828 | - |
| 414 | DWTX | Dogwood Therapeutics, Inc. | 62.72M | -4.90% | 121,690 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 62.49M | 1.92% | 243,357 | 11.57M |
| 416 | SER | Serina Therapeutics, Inc. | 62.23M | 10.36% | 74,522 | 130.00K |
| 417 | INKT | MiNK Therapeutics, Inc. | 61.08M | -0.25% | 55,919 | - |
| 418 | HRTX | Heron Therapeutics, Inc. | 59.86M | -0.06% | 1,174,295 | 151.18M |
| 419 | XLO | Xilio Therapeutics, Inc. | 58.76M | - | 10,255 | 64.09M |
| 420 | EXOZ | eXoZymes, Inc. | 58.29M | -0.32% | 5,627 | -700.00 |
| 421 | IMA | ImageneBio, Inc. | 56.76M | -1.57% | 14,763 | 800.00K |
| 422 | HYPD | Hyperion DeFi, Inc. | 56.56M | 4.30% | 509,211 | 1.40M |
| 423 | EDSA | Edesa Biotech, Inc. | 55.87M | -2.25% | 54,229 | - |
| 424 | ELTX | Elicio Therapeutics, Inc. | 52.56M | -2.44% | 391,635 | - |
| 425 | IBO | Impact BioMedical Inc. | 52.20M | 5.19% | 113,010 | 35.00K |
| 426 | APLM | Apollomics, Inc. | 50.90M | -0.13% | 504 | 8.84M |
| 427 | TIL | Instil Bio, Inc. | 50.53M | 0.95% | 22,439 | - |
| 428 | IMMP | Immutep Limited | 49.41M | -11.30% | 509,330 | 13.79M |
| 429 | TVGN | Tevogen Inc. | 48.90M | 2.04% | 15,398 | - |
| 430 | ANVS | Annovis Bio, Inc. | 48.57M | 1.79% | 1,201,834 | - |
| 431 | GRCE | Grace Therapeutics, Inc. | 48.17M | 3.15% | 48,336 | - |
| 432 | MCRB | Seres Therapeutics, Inc. | 47.02M | -5.59% | 54,045 | 1.88M |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 46.55M | -2.45% | 969,824 | 21.00M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 44.95M | 2.59% | 157,856 | 13.56M |
| 435 | MREO | Mereo BioPharma Group plc | 44.71M | - | 1,187,398 | 500.00K |
| 436 | CLNN | Clene Inc. | 42.14M | -8.12% | 140,141 | 197.00K |
| 437 | CELU | Celularity Inc. | 40.52M | -0.71% | 205,658 | 26.55M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 40.25M | -8.57% | 301,511 | 35.09M |
| 439 | VERU | Veru Inc. | 39.90M | -4.10% | 210,954 | 16.89M |
| 440 | LITS | Lite Strategy, Inc. | 39.13M | 3.60% | 329,736 | - |
| 441 | CRVO | CervoMed Inc. | 38.25M | -1.56% | 128,120 | 331.30K |
| 442 | ATYR | aTyr Pharma, Inc. | 38.12M | -9.59% | 1,731,686 | 190.00K |
| 443 | KPTI | Karyopharm Therapeutics Inc. | 36.29M | -0.62% | 991,814 | 146.62M |
| 444 | FLNA | Filana Therapeutics, Inc. | 34.72M | -6.96% | 386,702 | - |
| 445 | KYNB | Kyntra Bio, Inc. | 32.51M | 0.75% | 23,776 | 4.62M |
| 446 | CNTX | Context Therapeutics Inc. | 32.25M | 0.17% | 2,002,754 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 31.47M | -3.45% | 28,021 | 31.52M |
| 448 | BYSI | BeyondSpring Inc. | 31.25M | -0.52% | 30,904 | 1.88M |
| 449 | BCTX | BriaCell Therapeutics Corp. | 31.13M | -1.93% | 96,205 | - |
| 450 | NXTC | NextCure, Inc. | 30.39M | -5.14% | 90,561 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 28.65M | -4.67% | 33,566 | - |
| 452 | IGC | IGC Pharma, Inc. | 28.48M | -1.11% | 820,621 | 1.11M |
| 453 | QNTM | Quantum BioPharma Ltd. | 27.98M | 8.12% | 173,400 | - |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 27.94M | -2.37% | 20,662 | - |
| 455 | RADX | Radiopharm Theranostics Limited | 27.85M | 1.52% | 58,487 | 9.34M |
| 456 | ESLA | Estrella Immunopharma, Inc. | 27.64M | -3.65% | 27,293 | - |
| 457 | CVM | CEL-SCI Corporation | 26.74M | 2.01% | 66,535 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 25.92M | 2.03% | 114,343 | 797.92K |
| 459 | EVAX | Evaxion A/S | 25.60M | -1.92% | 21,866 | 7.49M |
| 460 | ATOS | Atossa Therapeutics, Inc. | 24.75M | -1.20% | 35,034 | - |
| 461 | ACTU | Actuate Therapeutics, Inc. | 24.73M | -3.74% | 259,000 | - |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 24.41M | -2.14% | 174,110 | - |
| 463 | NNVC | NanoViricides, Inc. | 23.92M | 2.94% | 650,289 | - |
| 464 | PLRZ | Polyrizon Ltd. | 23.82M | 2.63% | 69,316 | - |
| 465 | PBM | Psyence Biomedical Ltd. | 22.89M | 11.11% | 173,938 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 22.54M | -5.65% | 23,028 | 330.00K |
| 467 | PDSB | PDS Biotechnology Corporation | 22.34M | 35.33% | 80,847,334 | - |
| 468 | LGVN | Longeveron Inc. | 22.06M | -5.59% | 61,879 | 1.19M |
| 469 | LTRN | Lantern Pharma Inc. | 21.86M | - | 114,360 | - |
| 470 | CLRB | Cellectar Biosciences, Inc. | 21.83M | - | 65,736 | - |
| 471 | AKTX | Akari Therapeutics, Plc | 21.49M | -2.30% | 39,960 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 21.06M | -4.16% | 404,676 | - |
| 473 | GRDX | GridAI Technologies Corp. | 21.03M | 3.85% | 179,552 | - |
| 474 | GTBP | GT Biopharma, Inc. | 20.98M | 35.08% | 524,297 | - |
| 475 | PTN | Palatin Technologies, Inc. | 20.87M | 13.22% | 699,549 | 12.88M |
| 476 | TCRX | TScan Therapeutics, Inc. | 20.76M | -4.40% | 1,103,900 | 7.11M |
| 477 | NEUP | Neuphoria Therapeutics Inc. | 20.54M | 1.88% | 12,427 | -13.27K |
| 478 | MRKR | Marker Therapeutics, Inc. | 19.51M | 1.74% | 17,374 | 3.55M |
| 479 | NCEL | NewcelX Ltd. | 18.95M | -0.76% | 6,840 | - |
| 480 | ALLR | Allarity Therapeutics, Inc. | 18.62M | -4.10% | 113,157 | 345.00K |
| 481 | LPCN | Lipocine Inc. | 18.30M | -2.20% | 27,313 | 1.57M |
| 482 | BCDA | BioCardia, Inc. | 18.02M | 10.19% | 595,642 | 3.00K |
| 483 | CMMB | Chemomab Therapeutics Ltd. | 17.75M | -5.04% | 105,533 | - |
| 484 | NIKI | Niki BioSolutions, Inc. | 17.16M | 2.28% | 78,223 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 17.04M | -3.77% | 135,800 | - |
| 486 | CNSY | Cerenome, Inc. | 16.47M | -6.67% | 155,070 | 4.20M |
| 487 | PASG | Passage Bio, Inc. | 15.82M | -1.70% | 30,122 | - |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 15.73M | -1.36% | 209,025 | 7.11M |
| 489 | DYAI | Dyadic International, Inc. | 15.46M | -12.31% | 491,971 | 3.80M |
| 490 | BIVI | BioVie Inc. | 15.46M | 6.22% | 630,141 | - |
| 491 | PLUR | Pluri Inc. | 15.31M | 5.08% | 6,575 | 1.02M |
| 492 | ENLV | Enlivex Ltd. | 15.12M | -9.90% | 304,324 | - |
| 493 | MBRX | Moleculin Biotech, Inc. | 15.10M | 8.42% | 719,190 | - |
| 494 | MLEC | Moolec Science SA | 14.77M | 1.00% | 120,545 | 7.83M |
| 495 | HIND | Vyome Holdings, Inc. | 14.46M | - | 5,017 | 129.73K |
| 496 | AEON | AEON Biopharma, Inc. | 14.28M | -12.45% | 6,189,531 | - |
| 497 | LSTA | Lisata Therapeutics, Inc. | 14.06M | -4.29% | 169,191 | 100.00K |
| 498 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.82M | 1.33% | 10,205 | - |
| 499 | CALC | CalciMedica, Inc. | 13.66M | 1.01% | 101,282 | - |
| 500 | ICU | SeaStar Medical Holding Corporation | 13.53M | 1.34% | 11,203 | 1.71M |